The Living Guidelines: STEMI Thienopyridines Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Clopidogrel 75 mg per day orally should be added to aspirin in patients with STEMI regardless of whether they undergo reperfusion with fibrinolytic therapy or do not receive reperfusion therapy. (Class I, Level of Evidence: A) Treatment with clopidogrel should continue for at least 14 days. (Class I, Level of Evidence: B)

 AHA / ACC 2007 STEMI Guidelines Thienopyridines Class I Recommendation 1 should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. In patients taking clopidogrel in whom CABG is planned, the drug should be withheld for at least 5 days and preferably for 7 days unless the urgency for revascularization outweighs the risks of excess bleeding. (Class I, Level of Evidence: B)

 AHA / ACC 2007 STEMI Guidelines Thienopyridines Class I Recommendation 2 should be: CLASS I CLASS IIa CLASS IIb CLASS III